Regulatory Affairs & Submissions · Healthcare & Life Sciences
Should you build or buy Medical Device Complaint Management & MDR Reporting?
Medical device complaint management and MDR reporting software handles the intake, investigation, and regulatory disposition of post-market device complaints under FDA 21 CFR Part 803 and EU MDR Article 87/88. It provides validated, audit-trail-ready workflows for determining whether adverse events meet reporting thresholds, generating MDR submissions to the FDA and vigilance reports to notified bodies, and maintaining the complaint file that regulators inspect during audits.
The build-vs-buy decision for Medical Device Complaint Management and MDR Reporting turns on whether your organization needs a fully validated, audit-ready system backbone and how far you can extend vendor defaults to match your specific device codes, investigation decision trees, and regulatory submission templates; the compliance infrastructure and the customization layer pull in different directions here.
Build it, buy it, or bridge?
When building makes sense
The build case for complaint management and MDR reporting applies at the layer above the validated backbone, not to the backbone itself. The compliance infrastructure — 21 CFR Part 11 audit trails, EUDAMED integration, and the validated system status that FDA inspectors look for — is not something an internal team can assemble from scratch without years of IQ/OQ/PQ qualification work and direct regulatory exposure. What is genuinely buildable is the decision logic on top: custom complaint code taxonomies, investigation decision trees that reflect your specific device portfolio, AI-assisted root cause classification, and signal detection analytics tuned to your product's adverse event profile. For device makers with large complaint volumes and capable data engineering teams, those AI layers can add real analytical value that vendor platforms don't natively provide. The question is whether you're building the intelligent layer or the compliance layer — those are different problems with different risk profiles.
When buying makes sense
Buying makes sense for any device company with active complaint files and FDA or notified-body audit exposure. Platforms like Greenlight Guru, MasterControl, and Veeva Vault QMS carry the validation burden — IQ/OQ/PQ documentation, 21 CFR Part 11 compliance, and EUDAMED integration — that otherwise falls entirely on internal engineering and regulatory affairs. That vendor validation documentation also accelerates a device maker's own qualification timeline, which matters when complaint management is on the critical path to ISO 13485 certification or FDA clearance. Beyond the compliance argument, buying delivers pre-built MDR reporting workflows, reporting threshold decision trees, and audit-ready documentation structures that would take a dedicated team 12-24 months to build and qualify from scratch at similar total cost.
The desk read
Complaint management for medical devices is one of the few software categories where the compliance infrastructure is what you're buying. FDA 21 CFR Part 803 and EU MDR Article 87/88 require validated system status, audit-chain documentation, and EUDAMED integration that take years to achieve. Platforms like Greenlight Guru, MasterControl, and Veeva Vault QMS carry that validation burden, and no device maker has been widely documented as replacing them with a self-built system that survived an FDA audit intact.
The build case gets real for the layer on top of the validated backbone. Complaint code taxonomies, investigation decision trees, and regulatory submission templates reflect a company's specific product portfolio and regulatory strategy in ways vendor defaults don't fully capture. Extending a validated platform with custom investigation workflows, AI-assisted root cause analysis, and signal detection is feasible. Replacing the validated backbone itself is a different calculation, one where liability exposure from a self-built system without vendor indemnification weighs heavily regardless of the technical capability to build it.
Frequently asked
What is Medical Device Complaint Management and MDR Reporting software?
Medical device complaint management and MDR reporting software handles the intake, investigation, and regulatory disposition of post-market device complaints under FDA 21 CFR Part 803 and EU MDR Article 87/88. It provides validated, audit-trail-ready workflows for MDR submissions to the FDA and vigilance reports to notified bodies, and maintains the complaint file that regulators inspect during audits.
When does building Medical Device Complaint Management make sense?
Building makes sense for the investigation and analytics layer on top of a validated platform — custom complaint code taxonomies, AI-assisted root cause classification, and signal detection tuned to your device portfolio. Replacing the validated compliance backbone itself is a different problem that no device maker has widely demonstrated completing successfully.
When does buying Medical Device Complaint Management make sense?
Buying makes sense for any device company with FDA or notified-body audit exposure. The vendor carries the 21 CFR Part 11 validation burden and EUDAMED integration, and vendor IQ/OQ/PQ documentation accelerates a device maker's own qualification timeline.
What are the main Medical Device Complaint Management vendors?
Representative vendors include Greenlight Guru, MasterControl, Sparta Systems / Honeywell (TrackWise), Veeva (Vault QMS). B4 Pro scores the full set.
What is the difference between complaint management and MDR reporting?
Complaint management covers the full intake-to-resolution workflow: logging complaints, investigating root causes, and determining corrective action. MDR reporting is specifically the regulatory submission step — determining whether a complaint meets FDA's threshold for a Medical Device Report and generating the submission within the required 30-day window. Both functions are typically managed in the same validated platform because the complaint investigation record feeds directly into the MDR determination.